EUVIMEDOpdag EUVIMED
Open access

Characterizing public comments via Regulations.gov in response to proposed cannabis rescheduling in the United States

Vijay M Tiyyala, Cerina Dubois iD, Clarissa Madar, Ryan Vandrey iD, Johannes Thrul iD, Mark Dredze iD, John W Ayers iD

Addiction · 2026-09 · 121 (9) · 2450-2456

DOI: 10.1111/add.70410 ↗

At a glance

Journal article in Addiction, published online on 2026-04-24. Written by Vijay M Tiyyala and 6 co-authors. Institution: Department of Computer Science, Johns Hopkins University, Baltimore, MD, USA. Major MEDLINE topics: Drug and Narcotic Control, Public Opinion, Cannabis. 25 references. The full text is freely available in PubMed Central. Funded by: National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA), NCATS NIH HHS, NIDA NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aims

The United States Drug Enforcement Administration's (DEA) proposed rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act marks a significant shift in federal policy. Understanding public sentiment toward this policy is critical for guiding the current cannabis rescheduling effort as well as future reforms. The objective of this study is to characterize public comments submitted to Regulations.gov regarding the DEA's cannabis rescheduling proposal and identify underlying justifications for support or opposition.

Design

A mixed‐methods analysis was conducted.

Setting

Online public comments submitted to Regulations.gov regarding the DEA's cannabis rescheduling proposal.

Participants

42 913 public comments submitted between 21 May and 22 July 2024.

Measurements

Comments were analyzed for sentiment towards the proposed rescheduling (support, oppose or insufficient rescheduling) and thematic justifications using manual and automated natural language processing techniques. A two‐stage annotation approach was employed: manual coding of 200 randomly sampled comments by multiple independent evaluators, followed by automated classification of all 42 913 comments using open source Large Language Model (LLM) validated against the manual annotations.

Findings

Using LLM‐based classification validated against human annotations [88% agreement, F1 (harmonic mean of precision and recall) = 0.86], we found that among 42 913 comments, 28.85% [95% confidence interval (CI) = 28.44%–29.24%] supported rescheduling, 6.74% (95% CI = 6.50%–6.99%) opposed and 63.50% (95% CI = 63.06%–63.99%) deemed the proposal insufficient, favoring further rescheduling or complete de‐scheduling of cannabis. Among the 200 manually annotated comments, therapeutic benefits (56.7%, 95% CI = 46.7%–66.7%) and economic impacts (27.8%, 95% CI = 18.9%–37.8%) were the most common justifications among supporters. Public health risks (100.0%, 95% CI = 100.0%–100.0%), addictiveness concerns (71.4%, 95% CI = 42.9%–100.0%) and concerns about underage use (57.1%, 95% CI = 14.3%–85.7%) were predominant in opposing comments. Insufficient rescheduling comments cited therapeutic benefits (37.8%, 95% CI = 28.5%–48.0%), economic impacts (28.6%, 95% CI = 19.4%–37.8%) and criminal justice reform (26.5%, 95% CI = 18.4%–35.7%) as primary justifications.

Conclusions

Public sentiment on Regulations.gov supports the United States Drug Enforcement Administration's proposal for cannabis rescheduling, though the majority views the proposed Schedule III classification as inadequate and supports further rescheduling or complete de‐scheduling of cannabis.

Subjects

MeSH terms (MEDLINE)

Drug and Narcotic ControlPublic OpinionCannabisUnited StatesHumans

Author keywords

artificial intelligencecannabis regulationdrug schedulinge‐rulemakingnatural language processingpublic health policy

Authors and institutions

  • Department of Computer Science, Johns Hopkins University, Baltimore, MD, USA.
  • Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
  • Centre for Alcohol Policy Research, La Trobe University, Melbourne, Australia.
  • Altman Clinical Translational Research Institute, University of California San Diego, La Jolla, CA, USA.

ORCID profiles: Cerina Dubois, Ryan Vandrey, Johannes Thrul, Mark Dredze, John W Ayers

Funding

  • National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA)
  • NCATS NIH HHS
  • NIDA NIH HHS
  • Burroughs Wellcome Fund for Innovations in Regulatory Science

Cite

APA

Tiyyala, V. M., Dubois, C., Madar, C., Vandrey, R., Thrul, J., Dredze, M., & Ayers, J. W. (2026). Characterizing public comments via Regulations.gov in response to proposed cannabis rescheduling in the United States. Addiction, 121(9), 2450-2456. https://doi.org/10.1111/add.70410

Vancouver

Tiyyala VM, Dubois C, Madar C, Vandrey R, Thrul J, Dredze M, et al. Characterizing public comments via Regulations.gov in response to proposed cannabis rescheduling in the United States. Addiction. 2026;121(9):2450-2456. doi:10.1111/add.70410

BibTeX
@article{Tiyyala2026,
  author = {Tiyyala, Vijay M and Dubois, Cerina and Madar, Clarissa and Vandrey, Ryan and Thrul, Johannes and Dredze, Mark and Ayers, John W},
  title = {Characterizing public comments via Regulations.gov in response to proposed cannabis rescheduling in the United States},
  journal = {Addiction},
  year = {2026},
  volume = {121},
  number = {9},
  pages = {2450--2456},
  doi = {10.1111/add.70410}
}
Start for free →